These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9717953)

  • 1. Tamoxifen in early breast cancer.
    Arriagada R
    Lancet; 1998 Aug; 352(9125):403-4. PubMed ID: 9717953
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen in early breast cancer.
    Bryce CJ
    Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: a randomized study.
    Gundersen S; Hannisdal E; Søreide JA; Skarstein A; Varhaug JE
    Breast Cancer Res Treat; 1995; 36(1):49-53. PubMed ID: 7579506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing endocrine therapy for breast cancer.
    Winer EP
    J Clin Oncol; 2005 Mar; 23(8):1609-10. PubMed ID: 15755964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current issues in adjuvant hormone therapy of breast cancer].
    Semiglazov VF; Semiglazov VV
    Vopr Onkol; 2003; 49(6):771-5. PubMed ID: 14976929
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen in early breast cancer.
    Benson JR
    Lancet; 1998 Aug; 352(9125):404-5. PubMed ID: 9717955
    [No Abstract]   [Full Text] [Related]  

  • 7. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New stars in the sky of treatment for early breast cancer.
    Piccart-Gebhart MJ
    N Engl J Med; 2004 Mar; 350(11):1140-2. PubMed ID: 15014188
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen therapy--long-term results and complications.
    Moore MP; Kinne DW
    Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of aromatase inhibitor (AI) in the treatment of breast cancer.
    Irawan C; Abdulmuthalib
    Acta Med Indones; 2005; 37(1):43-8. PubMed ID: 15879638
    [No Abstract]   [Full Text] [Related]  

  • 11. The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients.
    Bièche I; Parfait B; Noguès C; Andrieu C; Vidaud D; Spyratos F; Lidereau R; Vidaud M
    Oncogene; 2001 Oct; 20(47):6955-9. PubMed ID: 11687975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian suppression for breast cancer: an effective treatment in search of a home.
    Krop IE; Winer EP
    J Clin Oncol; 2005 Sep; 23(25):5869-72. PubMed ID: 16087947
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen for patients with estrogen receptor-negative breast cancer.
    Swain SM
    J Clin Oncol; 2001 Sep; 19(18 Suppl):93S-97S. PubMed ID: 11560981
    [No Abstract]   [Full Text] [Related]  

  • 14. Current and future roles of adjuvant endocrine therapy in the management of early carcinoma of the breast.
    Baum M; Benson JR
    Recent Results Cancer Res; 1996; 140():215-26. PubMed ID: 8787064
    [No Abstract]   [Full Text] [Related]  

  • 15. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
    [No Abstract]   [Full Text] [Related]  

  • 16. Aromatase inhibitors for breast cancer: pharmacoeconomic considerations.
    Higa GM
    Expert Opin Pharmacother; 2001 Jun; 2(6):987-95. PubMed ID: 11585014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do.
    Higgins MJ; Wolf AC
    Oncology (Williston Park); 2009 Jan; 23(1):40, 42, 44. PubMed ID: 19283920
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine therapy for early breast cancer.
    Hussain SA; Williams S; Stevens A; Rea DW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
    Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
    [No Abstract]   [Full Text] [Related]  

  • 20. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P; Marty M
    Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.